Click here to receive MS news via e-mail
A Canadian research group is looking at the use of cannabis oil as a treatment for neuropathic pain in multiple sclerosis patients.
Medical marijuana now available in controlled-dose capsules in New York. Read more here.
Using mice models, the study is investigating the pain relief properties of two types of cannabinoid oil produced by CanniMed Therapeutics specifically for chronic pain associated with multiple sclerosis. The researchers are using CanniMed 10:10 which contains equal measures of CBD (cannabidiol) and THC (tetrahydrocannabinol) and the company’s CanniMed 1:20 which only contains CBD.
The study aims to discover how effective the medical marijuana is at treating MS-associated pain and also to discover the molecular effects of the oils and exactly how it works as a pain relief treatment. Find out more about this study here.
MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews